Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytokines and immune mediators are a diverse group of small, secreted proteins that act as signaling molecules to regulate the immune system. They mediate communication between cells to coordinate immunity, inflammation, tissue repair, and homeostasis. They are produced by a wide range of immune and non-immune cells and exert their effects by binding to specific cell-surface receptors, triggering intracellular signaling cascades that alter gene expression and cellular behavior. Dysregulation of cytokine production or response is implicated in numerous diseases, including autoimmune disorders, infectious diseases, and cancer. Therapeutic strategies targeting these pathways include monoclonal antibodies, recombinant cytokines, and small molecule inhibitors.
Monoclonal antibodies neutralize cytokines or block their receptors; recombinant cytokines enhance immune responses; small molecule inhibitors block intracellular signaling pathways downstream of cytokine receptors; corticosteroids broadly suppress cytokine production.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytokines and Immune Mediators (N/A).